Stockscreener 앱 받기
26.51
2.54%
-0.69
전일 마감가:
$27.20
열려 있는:
$27.36
하루 거래량:
128.43K
Relative Volume:
0.52
시가총액:
$1.82B
수익:
-
순이익/손실:
$-48.26M
주가수익비율:
-33.56
EPS:
-0.7899
순현금흐름:
$-45.04M
1주 성능:
-1.85%
1개월 성능:
+30.21%
6개월 성능:
+76.62%
1년 성능:
+65.17%
1일 변동 폭
$26.03
$27.88
1주일 범위
$25.47
$27.88
52주 변동 폭
$11.32
$28.96
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
26.51 | 1.82B | 0 | -48.26M | -45.04M | -0.7899 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-13 | 개시 | Needham | Buy |
| 2025-06-04 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-03-13 | 개시 | Guggenheim | Buy |
| 2025-03-07 | 개시 | RBC Capital Mkts | Outperform |
| 2025-02-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-08-16 | 개시 | H.C. Wainwright | Buy |
| 2022-06-16 | 개시 | ROTH Capital | Buy |
모두보기
Gh Research Plc 주식(GHRS)의 최신 뉴스
A3CUAZ Forecast — Price Target — Prediction for 2027 - TradingView
GH Research (GHRS) price target increased by 18.94% to 40.04 - MSN
Price-Driven Insight from (GHRS) for Rule-Based Strategy - Stock Traders Daily
Price to sales forward of GH Research PLC – NASDAQ:GHRS - TradingView
GHRSGH Research PLC Options - Finviz
GH RESEARCH PLC (GHRS) Stock Chart - ChartMill
GH Research Plc Actuals & Estimates (FWB:1KA) - TradingView
Pre-Market Movement | GH Research Shares Surge to 52-Week High - 富途牛牛
GHRS Forecast — Price Target — Prediction for 2027 - TradingView
GHRS Stock Price and Chart — NASDAQ:GHRS - TradingView
(GHRS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
GH Research PLC stock hits 52-week high at 25.98 USD - Investing.com
GH Research Shareholders Approve Director Slate and 2026 Auditor at June AGM - TipRanks
GH Research PLC (GHRS) re-elects directors and ratifies PwC Ireland at AGM - Stock Titan
GH Research Plc Actuals & Estimates (MUN:1KA) - TradingView
These analysts revise their forecasts on GH Research after Q1 results - MSN
GH Research PLC (GHRS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GH Research PLC (GHRS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
What GH Research (GHRS)'s Phase 2a Postpartum Depression Breakthrough Means For Shareholders - simplywall.st
GH Research PLC (GHRS) Valuation: PE, PB & Fair Value Analysis - TradingKey
GH Research PLC (GHRS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GH Research PLC (GHRS) Institutional Confidence - TradingKey
GH Research PLC (GHRS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GH Research PLC (GHRS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GH Research PLC (GHRS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GH Research PLC (GHRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
(GHRS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
GH Research (GHRS) Stock Valuation After Positive Phase 2a Mebufotenin Data In Postpartum Depression - Sahm
GH Research (GHRS) Bounces 2.23% as Shares Test Key Resistance at $22.18Exhaustion Gap - newsline.com
GHRS Q1 2026 Earnings: Clinical-Stage Biotech Reports Wider-Than-Expected Loss, Stock Rises on Pipeline Progress - dars.gov.et
GHRS Q1 2026 Earnings: Clinical-Stage Biotech Reports Narrower-Than-Expected Operating Loss Amid Pipeline ProgressEarnings Power Value - newsline.com
Do GH Research’s (GHRS) Phase 2a Postpartum Data Subtly Reframe Its Broader Depression Strategy? - simplywall.st
GH Research PLC (GHRS) Gains Ground After Testing Support, Resistance in FocusAscending Triangle - newsline.com
GH Research Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues Clinical DevelopmentReturn On Assets - newsline.com
GHRS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
H.C. Wainwright Maintains Buy Rating on GH Research (GHRS) - Insider Monkey
GH Research earnings ahead: Can cash sustain Phase 3 ambitions? - Investing.com
5 Stocks That Have the Potential to Rise 1000% - Insider Monkey
(GHRS) Risk Channels and Responsive Allocation - Stock Traders Daily
GH Research Publishes Positive Phase 2a Postpartum Depression Data and Secures CINP 2026 Slots for GH001 - TipRanks
GH Research (NASDAQ: GHRS) highlights Phase 2 GH001 results in postpartum and treatment-resistant depression - Stock Titan
GH Research publishes phase 2a postpartum depression results By Investing.com - Investing.com Australia
GH Research publishes phase 2a postpartum depression results - Investing.com
GH Research Announces Publication of Phase 2a Postpartum Depression Results - Yahoo Finance UK
GHRS Q1 2026 Earnings: Miss on EPS as Clinical-Stage Biotech Deepens R&D InvestmentFinancial Health Score - newsline.com
Psychedelic drug stocks are surging after Trump's order to fast-track development for medical use - AOL.com
GH Research (GHRS) Surges Over 7%: Testing Key Resistance at $25.19Short Term Trading Ideas - dars.gov.et
GH Research (GHRS) Surges 7.19% as Breakout Above $25.19 Resistance Becomes Key TestOvernight Profile - The Legal Advocate
Certain Options of GH Research PLC are subject to a Lock-Up Agreement Ending on 30-MAY-2026. - marketscreener.com
62,029,395 Common Stock of GH Research PLC are subject to a Lock-Up Agreement Ending on 30-MAY-2026. - marketscreener.com
GH Research (GHRS) Jumps 3.35% as Shares Approach Key Resistance at $24.0Insider Selling Alerts - The Legal Advocate
Gh Research Plc (GHRS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):